Axios

@axios ↗

Deleted No

Hibernated Yes

Last Checked Oct. 7, 2022

Created

Wed Aug 24 20:23:01 +0000 2022

Likes

Retweets

Source

Twitter Web App

View Raw Data

JSON Data

View on Twitter

Likely Available

Axios @axios

The findings come from the first published randomized trial to examine the effects of psilocybin in addiction and surpass any previously published study of the naturally occurring psychedelic drug, said Charles Marmar, chairman of NYU Langone's psychiatry department. https://t.co/uctcZJaNyX — PolitiTweet.org

Posted Aug. 24, 2022 Hibernated

Preceded By

Axios @axios

MDMA, psilocybin and LSD — combined with psychotherapy — are being explored for treating a range of addictions and mental health disorders, including treatment-resistant depression and PTSD. https://t.co/ZR6rDxanBH — PolitiTweet.org

Posted Aug. 24, 2022 Hibernated

Followed By

Axios @axios

This double-blind trial led by the researchers at NYU Langone compared the effectiveness of 12 weeks of psychotherapy delivered with two day-long medication sessions of either psilocybin or an active placebo. https://t.co/ZR6rDxanBH https://t.co/jxevAukxvs — PolitiTweet.org

Posted Aug. 24, 2022 Hibernated